showed that RIPK1, the key gene of necroptosis, was commonly overexpressed in glioblastoma and positively correlated with worse survival (25) and RIPK3 was also identified as a negative prognostic biomarker in low-grade glioma (26). This evidence concerns the gene RIPK1 and glioblastoma.